^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    IGF1 elevation

    i
    Entrez ID:
    3479
    Related biomarkers:
    Expression
    Mutation
    Apply
    Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease (NCT00446082)
    Phase 1
    Novartis Pharmaceuticals
    Completed
    Last update posted :
    12/21/2020
    Initiation :
    06/01/2006
    Primary completion :
    11/01/2013
    Completion :
    11/01/2013
    IGF1 • CHGA
    |
    IGF1 elevation
    |
    Signifor LAR (pasireotide long acting release)